Clinical Trials Directory

Trials / Completed

CompletedNCT04300738

Evaluation and Comparison of Two Biomarkers (VOP and SCC) for the Prognosis of the Occurrence of Clinical Cardiovascular Events

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
220 (actual)
Sponsor
Clinique Bizet · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of our study is to assess the Cardiovascular risk and the quality of the arteries by comparing the Coronary Calcium Score SCC measured with a CT scann and the Pulse Wave Velocity PWV measured with pOpmeter for the prognosis at 6 months of clinical events. Is there a superiority of PWV compared to SCC:

Detailed description

Two method of cardiovascular risk screening are compared in patient going for Coronary Calcium Score measurement in a outpatient clinic. Ct Scann is expensive, learning time is for at least 2 years, and the reliability is operator dependent. The Pulse Wave Velocity is measured using a new device with half an hour learning curve, and you get a result within 2 minutes. 1. A non-invasive medical device vs invasive 2. A better benefit-risk ratio 3. A lower diagnostic cost both for equipment and for qualification for use and learning time

Conditions

Interventions

TypeNameDescription
DEVICECCS wit CT Scann measurementMeasurement with 2 devices

Timeline

Start date
2020-05-15
Primary completion
2021-02-05
Completion
2022-02-15
First posted
2020-03-09
Last updated
2022-03-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04300738. Inclusion in this directory is not an endorsement.